Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens and progesterone are key in regulating melasma pigmentation.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.